FOSL1, encoding FRA-1, is overexpressed in most solid tumors including lung cancer [55], breast cancer [56], ovarian cancer [57], prostate cancer [58], gastric cancer [59], colorectal cancer [60, 61], head and neck squamous cell carcinomas [62], and GBM [45, 63]. Here, FOSL1 is linked to prostate cancer.